Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
05.11.24
/
50%
€457.60
Target price
05.11.25
€460.55
Performance (%)
-31.23%
Price
08.08.25
€314.70
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc. is performing very badly with a performance of -31.23%. This prediction currently runs until 05.11.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -21.217% | -21.217% |
| iShares Core DAX® | 3.109% | -0.124% |
| iShares Nasdaq 100 | 3.088% | 4.723% |
| iShares Nikkei 225® | 4.760% | 5.051% |
| iShares S&P 500 | 1.840% | 3.430% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $510.00 to $503.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€404.90
14.07.25
14.07.25
€442.35
14.07.26
14.07.26
-22.28%
08.08.25
08.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.85
06.05.25
06.05.25
€455.98
06.05.26
06.05.26
-18.86%
08.08.25
08.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.25
23.12.24
23.12.24
€480.45
23.12.25
23.12.25
-17.02%
08.08.25
08.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€464.36
05.08.25
05.08.25
-24.98%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.30
01.02.24
01.02.24
€404.41
01.02.25
01.02.25
10.22%
02.02.25
02.02.25